Biosensor Can Detect Airborne Bird Flu in Under Five Minutes
A portable biosensor cuts detection time for airborne H5N1 virus particles to less than five minutes -- significantly faster than conventional PCR tests.
A portable biosensor cuts detection time for airborne H5N1 virus particles to less than five minutes -- significantly faster than conventional PCR tests.
A portable biosensor cuts detection time for airborne H5N1 virus particles to less than five minutes — significantly faster than conventional PCR tests.
Read MoreVisby Medical’s handheld PCR test that differentiates between influenza A, B, and COVID-19 received FDA clearance and a CLIA waiver.
Read MoreShare your expertise in this 5–7 minute survey to influence smarter tools for diagnostics, remote data access, and inventory management. Join us in shaping innovative, patient-focused solutions for better sleep health and clinical efficiency. Together, we can design tools that truly work for professionals like you.
Read MoreIMT Analytics AG has launched alveo, an advanced, high-fidelity lung simulator explicitly designed for device manufacturers, simulation centers, healthcare professionals, and research institutions.
Read MoreResearchers used artificial intelligence to analyze urine samples, accurately forecasting COPD symptom flare-ups seven days before they occurred.
Read MoreSiemens Healthineers now offers Atellica Integrated Automation on the Atellica CI Analyzer.
Read MoreStill the gold standard in measuring blood oxygen levels, arterial blood gas analysis continues to move out of the diagnostics lab and straight to the patient’s bedside.
Read MoreNonin’s partnership with EnsoData aims to bring accessible sleep testing and diagnosis to all audiences, including patients with limited access to care.
Read MoreThe home sleep test, worn on the wrist and finger, was validated against polysomnography for sleep apnea and sleep staging.
Read MoreWhile wearables can detect potential respiratory infections, a new study shows that only a quarter of individuals follow up with at-home testing.
Read MoreThe Centers for Disease Control and Prevention says a glitch in its bird flu test hasn’t harmed the agency’s outbreak response.
Read MoreAntibiotics in tuberculosis patients can be accurately monitored through a fingerprint sweat test, offering a less invasive alternative to blood tests, research finds.
Read MorebioMérieux received US FDA 510(k) clearance for its Vitek Reveal AST System, which reports results directly from positive blood cultures.
Read MoreThe Roche Digital Pathology Dx whole slide imaging system is intended to assist pathologists in reviewing and interpreting digital images of scanned pathology slides to aid diagnose.
Read MoreThe FDA issued emergency use authorization to Roche’s cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test, the company reports.
Read MoreThe Mini-Wright Peak Flow Meter was one of only two peak flow meters that met the ISO 23747 measuring “standards of accuracy.”
Read MoreThe BioFire SpotFire Respiratory/Sore Throat (R/ST) Panel received FDA 510(k) clearance and CLIA) waiver approval, according to bioMérieux.
Read MoreNow FDA-cleared for whole blood analysis, Abbott’s i-Stat TBI cartridge can be used to assess suspected concussion at the point-of-care in as little as 15 minutes. Abbott says this may someday allow future testing outside traditional healthcare settings, such as on the sidelines of sporting events.
Read MoreUniversity Medical Devices (UMD) has closed its first round of seed funding after raising $1.6 million to develop its MicroWash nasal specimen collection device for diagnosing upper respiratory infections.
Read MoreUsing gene editing proteins combined with nanopore sensing technology, new research shows that testing for pathogens could become faster and more accessible.
Read MoreNearly 5 million US adults who smoke and formerly smoked are now recommended for testing.
Read MoreThe Pulmonary Fibrosis Foundation and Pulmonary Hypertension Association have developed a position statement that addresses gaps in the diagnosis and treatment of patients living with pulmonary hypertension related to interstitial lung disease.
Read MoreNew data suggests that at least 4 million people with post-viral syndrome similar to long-COVID may indeed have detectable immune responses to support a COVID diagnosis.
Read MoreThe document provides expert, opinion-based clinical practice guidance, along with test instructions, for a selection of commonly used tests which have documented clinimetric properties for people with cystic fibrosis.
Read More